This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Patricia M. Knight, PhD
Irvine, Calif

Arch Ophthalmol. 1991;109(11):1494-1495.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—This letter is in response to Dr Watt's letter concerning discoloration of an IOL model SI-18NGB manufactured by Allergan Medical Optics (AMO), Irvine, Calif. We appreciate the opportunity to address Dr Watt's concerns and will be sending a clinical researcher to observe this lens firsthand. In the meantime, we have consulted the manufacturing records of this IOL and found that 34 other lenses from the same batch have been implanted with no report of discoloration.

Dr Watt's description of a centrally located discoloration appears similar to our observations made during Food and Drug Administration core studies in 1987. Several investigators reported that under slit-lamp examination, eight subjects (1.6%) in the cohort were found to have a slight haze in the center of their SI-18B implant. However, all three investigators believed this haze to be clinically insignificant and noted no visual disturbance. In addition, all three investigators noted that . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?